Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer

Kachnic, L. A., Winter, K. A., Myerson, R. J., Goodyear, M. D., Abitbol, A. A., Streeter, O. E., Augspurger, M. E., Schefter, T. E., Katz, A. W., Fisher, B. J., Henke, L. E., Narayan, S., & Crane, C. H. (2022). Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. International Journal of Radiation Oncology*Biology*Physics, 112(1), 146–157. https://doi.org/10.1016/j.ijrobp.2021.08.008
Authors:
Lisa A. Kachnic
Kathryn A. Winter
Robert J. Myerson
Michael D. Goodyear
Andre A. Abitbol
Oscar E. Streeter
Mark E. Augspurger
Tracey E. Schefter
Alan W. Katz
Barbara J. Fisher
Lauren E. Henke
Samir Narayan
Christopher H. Crane
Affiliated Authors:
Lisa A. Kachnic
Publication Type:
Article
Unique ID:
10.1016/j.ijrobp.2021.08.008
PMID:
Publication Date:
Data Source:
Scopus

Record Created: